Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells (original) (raw)

1995, Journal of virology

Abstract

Subacute sclerosing panencephalitis is a slowly progressing fatal human disease of the central nervous system which is a delayed sequel of measles virus (MV) infection. A typical pathological feature of this disease is the presence of viral ribonucleocapsid structures in the form of inclusion bodies and the absence of infectious virus or budding viral particles. The mechanisms governing the establishment and maintenance of a persistent MV infection in brain cells are still largely unknown. To understand the mechanisms underlying MV persistence in neuronal cells, a tissue culture model was studied. Clone NS20Y/MS of the murine neuroblastoma C1300 persistently infected with the wild-type Edmonston strain of MV secretes relatively high levels of alpha/beta interferon (IFN). As shown previously, treatment of the persistently infected cultures with anti-IFN serum converted the persistent state into a productive infection indicated by the appearance of multinucleated giant cells. In this ...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (53)

  1. Baczko, K., U. G. Liebert, M. A. Billeter, R. Cattaneo, H. Budka, and V. ter Meulen. 1986. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J. Virol. 59:472-478.
  2. Baglioni, C. 1979. IF-induced enzymatic activities and their role in the antiviral state. Cell 17:225-264.
  3. Banerjee, A. K. 1987. Transcription and replication of rhabdoviruses. Micro- biol. Rev. 51:66-87.
  4. Barrett, P. N., K. Koschel, M. Carter, and V. ter Meulen. 1985. Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line. J. Gen. Virol. 66:1411-1421.
  5. Billeter, M. A., and R. Cattaneo. 1991. Molecular biology of defective mea- sles viruses persisting in the human central nervous system, p. 323-345. In D. Kingsbury (ed.), The paramyxoviruses. Plenum Press, New York.
  6. Billeter, M. A., R. Cattaneo, A. Schmid, D. Eschle, K. Ka ¨lin, G. Rebmann, S. A. Udem, R. D. Sheppard, K. Baczko, U. G. Liebert, S. Schneider- Schaulies, U. Brinckmann, and V. ter Meulen. 1989. Host and viral features in persistent measles virus infections of the brain, p. 356-366. In D. Kola- kofsky and B. W. J. Mahy (ed.), Genetics and pathogenicity of negative strand viruses. Elsevier, Amsterdam.
  7. Birrer, M. J., B. R. Bloom, and S. A. Udem. 1981. Characterization of measles virus polypeptides by monoclonal antibodies. Virology 108:381.
  8. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-687.
  9. Cattaneo, R., A. Schmid, M. A. Billeter, R. D. Sheppard, and S. A. Udem. 1988. Multiple viral mutations rather than host factors cause defective mea- sles virus gene expression in a subacute sclerosing panencephalitis cell line. J. Virol. 62:1388-1397.
  10. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
  11. Dubois-Dalque, M. 1979. Pathology of measles virus infection of the nervous system: comparison with multiple sclerosis. Int. Rev. Exp. Pathol. 19:101- 135.
  12. Fu, X.-Y. 1992. A transcription factor with SH2 and SH3 domains is directly activated by an interferon ␣-induced cytoplasmic protein tyrosine kinase(s). Cell 70:323-335.
  13. Gopas, J., D. Itzhaki, Y. Segev, S. Salzberg, B. Trink, N. Isakov, and B. Rager-Zisman. 1992. Persistent measles infection enhances major histocom- patibility complex class I expression and immunogenicity of murine neuro- blastoma cells. Cancer Immunol. Immunother. 34:313-320.
  14. Gutch, M. J., C. Daly, and N. C. Reich. 1992. Tyrosine phosphorylation is required for activation of an ␣ interferon transcription factor. Proc. Natl. Acad. Sci. USA 89:11411-11415.
  15. Hirano, A., M. Ayata, A. H. Wang, and T. Wong. 1993. Functional gene analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J. Virol. 67:1848-1853.
  16. Jourdan, M., X. G. Zhang, M. Portier, J.-M. Boiron, R. Bataille, and B. Klein. 1991. IFN-␣ induces autocrine production of IL-6 in myeloma cell lines. J. Immunol. 147:4402-4407.
  17. Ju, G., S. A. Udem, B. Rager-Zisman, and B. R. Bloom. 1978. Isolation of a heterogeneous population of temperature sensitive mutants of virus from persistently infected human lymphoblastoid cells. J. Exp. Med. 147:1637.
  18. Kamps, M. P., and B. M. Sefton. 1988. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosines. Onco- gene 2:305-315.
  19. Kamps, M. P., and B. M. Sefton. 1989. Acid and base hydrolysis of phos- phoproteins bound to Immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. Anal. Biochem. 176:22-27.
  20. Katze, M. G., J. Tomita, T. Black, R. M. Krug, B. Safer, and A. Hovanessian. 1992. Influenza virus regulates protein synthesis during infection by repress- ing autophosphosporylation and activity of the cellular 68,000-M r protein kinase. J. Virol. 62:3710-3717.
  21. Ke, S., C. Schindler, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Activation of transcription by IFN-␥ tyrosine phosphorylation of a 91kD DNA binding protein. Science 258:1808-1812.
  22. Kessler, D. S., S. A. Veals, X.-Y. Fu, and D. E. Levy. 1990. IFN-alpha regulates nuclear translocation and DNA binding affinity of ISGF3, a mul- timeric transcriptional activator. Genes Dev. 4:1753-1765.
  23. Kingsbury, D. W. 1990. Paramyxoviridae and their replication, p. 945-962. In B. N. Fields and D. M. Knipe (ed.), Virology, vol. 1. Raven Press, New York.
  24. Koromilas, A. E., S. Roy, G. N. Barber, M. G. Katz, and N. Sonnenberg. 1992. Malignant transformation by a mutant of the IFN-inducible sdRNA- dependent protein kinase. Science 257:1685-1689.
  25. Kristensson, K., and E. Norrby. 1986. Persistence of RNA viruses in the central nervous system. Annu. Rev. Microbiol. 40:159-184.
  26. Levy, D. E., D. S. Kessler, R. Pine, and J. E. Darnell, Jr. 1989. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 2:1352-1371.
  27. Liebert, U. G., S. Schneider-Schaulies, K. Baczko, and V. ter Meulen. 1990. Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J. Virol. 64:706-713.
  28. Linberg, R. A., W. H. Fischer, and T. Hunter. 1993. Characterization of a human protein threonine kinase isolated by screening an expression library with antibodies to phosphotyrosine. Oncogene 8:351-359.
  29. Muller, M., J. Brisco, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harper, G. Barbieri, B. A. Witthuhn, C. Schindler, S. Pellegrini, A. F. Wilks, J. N. Ihle, G. R. Stark, and I. M. Kerr. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-␣/␤ and ␥ signal transduc- tion. Nature (London) 366:129-135.
  30. Orvell, C. 1992. Paramyxoviruses, p. 177-205. In S. Spencer, M. Bendinelli, and H. Friedmen (ed.), Neuropathogenic viruses and immunity. Plenum Press, New York.
  31. Oyanagi, S., V. ter Meulen, M. Katz, and H. Koprowski. 1971. Comparison of subacute sclerosing panencephalitis and measles viruses: an electron mi- croscopic study. J. Virol. 7:176-187.
  32. Payne, F. E., J. V. Baublis, and H. H. Itabashi. 1969. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosis panencephalitis. N. Engl. J. Med. 281:585-595.
  33. Rager-Zisman, B., J. E. Egan, Y. Kress, and B. R. Bloom. 1984. Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J. Virol. 51:845-855.
  34. Raine, C. S., L. A. Feldman, R. D. Sheppard, and M. B. Bornstein. 1969. Ultrastructure of measles virus in cultures of hamster cerebellum. J. Virol. 4:169-181.
  35. Raine, C. S., L. A. Feldman, R. D. Sheppard, and M. B. Bornstein. 1971. Ultrastructural study of long-term measles infection in cultures of hamster dorsal-root ganglion. J. Virol. 8:318-329.
  36. Rammohan, K. W., H. F. McFarland, and D. E. McFarlin. 1981. Induction of subacute murine measles encephalitis by monoclonal antibody to virus hemagglutinin. Nature (London) 290:588-589.
  37. 2484 SEGEV ET AL. J. VIROL.
  38. Rataul, S. M., A. Hirano, and T. C. Wong. 1992. Irreversible modification of measles virus RNA in vitro by nuclear RNA-unwinding activity in human neuroblastoma cells. J. Virol. 66:1769-1773.
  39. Rysiecki, G., D. R. Gewert, and B. R. G. Williams. 1989. Constitutive ex- pression of a 2Ј-5Ј-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9:646-657.
  40. Schindler, C., S. Ke, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Interferon- dependent tyrosine phosphorylation of a latent cytoplasmatic transcription factor. Science 157:809-813.
  41. Schneider-Schaulies, S., U. G. Liebert, K. Baczko, R. Cattaneo, M. A. Bill- eter, and V. ter Meulen. 1989. Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology 171:525-534.
  42. Schneider-Schaulies, S., U. G. Liebert, K. Baczko, and V. ter Meulen. 1990. Restricted expression of measles virus in primary rat astroglial cells. Virology 177:802-806.
  43. Schneider-Schaulies, S., U. G. Liebert, B. Rager-Zisman, Y. Segev, M. Wolf- son, and V. ter Meulen. 1992. Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J. Virol. 66:5534-5541.
  44. Schneider-Schaulies, S., J. Schneider-Schaulies, M. Bayer, S. Loffler, and V. ter Meulen. 1993. Spontaneous differentiation-dependent regulation of mea- sles virus gene expression in human glial cells. J. Virol. 67:3375-3383.
  45. Schneider-Schaulies, S., and V. ter Meulen. 1992. Molecular aspects of measles virus induced central nervous system diseases, p. 419-449. In R. P. Ross (ed.), Molecular neurovirology. Humana Press Inc., Clifton, N.J. 45. Sheppard, R. D., C. S. Raine, M. B. Borenstein, and S. A. Udem. 1986. Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc. Natl. Acad. Sci. USA 83:7913- 7917.
  46. Spehner, D., A. Kirn, and R. Drillien. 1991. Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J. Virol. 65:6296-6300.
  47. Staeheli, P. 1990. Interferon induced proteins and the antiviral state. Adv. Virus Res. 38:147-200.
  48. ter Meulen, V., and M. J. Carter. 1984. Measles virus persistency and disease. Prog. Med. Virol. 30:44-61.
  49. ter Meulen, V., J. R. Stephenson, and H. W. Kreth. 1983. Subacute sclerosing panencephalitis. Compr. Virol. 18:105-159.
  50. Thomis, D. C., J. P. Doohan, and C. E. Samuel. 1992. Mechanism of inter- feron action: cDNA-structure, expression and regulation of interferon in- duced, RNA dependent P1/eIF-2␣ protein kinase from human cells. Virol- ogy 188:33-46.
  51. Velasquez, L., M. Fellous, G. R. Stark, and S. Pellegrini. 1992. A protein tyrosine kinase in the interferon ␣/␤ signalling pathway. Cell 70:313-322.
  52. Wong, T. C., M. Ayata, A. Hirano, Y. Yoshikawa, H. Tsuruoka, and K. Yamanouchi. 1989. Generalized and localized biased hypermutation affect- ing the matrix gene of a measles virus strain causing subacute sclerosing panencephlitis. J. Virol. 63:5464-5468.
  53. Wong, T. C., M. Ayata, S. Udea, and A. Hirano. 1991. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis from pro- genitor acute measles virus. J. Virol. 65:2191-2199.